MODERN STRATEGIES FOR THE TREATMENT OF GASTRIC AND DUODENAL PEPTIC ULCER DISEASE

Authors

  • Abdullayeva Shakhzoda Qodir qizi, Shamuradov Ilxom Ismailovich Samarkand State Medical University Author

Keywords:

Peptic ulcer disease, gastric ulcer, duodenal ulcer, Helicobacter pylori, eradication therapy, proton pump inhibitors, acid suppression, endoscopic treatment, gastrointestinal bleeding, ulcer recurrence, personalized treatment.

Abstract

Peptic ulcer disease of the stomach and duodenum remains a significant gastrointestinal disorder associated with mucosal damage, recurrent disease, and potentially serious complications. The development of modern diagnostic and therapeutic approaches has improved treatment effectiveness and reduced the risk of disease recurrence. This article examines contemporary strategies for the management of gastric and duodenal peptic ulcer disease, focusing on etiological factors, diagnostic methods, pharmacological treatment, and prevention of complications. Particular attention is given to Helicobacter pylori infection, nonsteroidal anti-inflammatory drug-associated ulcers, eradication therapy, and acid-suppressive medications. The role of proton pump inhibitors, potassium-competitive acid blockers, endoscopic procedures, and individualized therapeutic approaches is also discussed. The analysis demonstrates that successful management requires accurate identification of the underlying cause, appropriate selection of treatment regimens, confirmation of bacterial eradication, and continuous assessment of potential complications.

References

1.Sugimoto M., Kamada T., Ito M., Iwamoto J., Okimoto T. Evidence-based clinical practice guidelines for peptic ulcer disease 2026 // Journal of Gastroenterology. – 2026. – Vol. 61, No. 10. – P. 1361–1381.

2.Chey W.D., Howden C.W., Moss S.F., Morgan D.R., Greer K.B., Grover S., Shah S.C. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection // The American Journal of Gastroenterology. – 2024. – Vol. 119, No. 9. – P. 1730–1753.

3.Malfertheiner P., Megraud F., Rokkas T., Gisbert J.P., Liou J.M., Schulz C., Gasbarrini A., Hunt R.H., Leja M., O’Morain C., Rugge M., Suerbaum S., Tilg H., Sugano K., El-Omar E.M. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report // Gut. – 2022. – Vol. 71, No. 9. – P. 1724–1762.

4.Kamada T., Satoh K., Itoh T., Ito M., Iwamoto J., Okimoto T., Kanno T., Sugimoto M., Chiba T., Nomura S., Mieda M., Hiraishi H., Yoshino J., Takagi A., Watanabe S., Koike K. Evidence-based clinical practice guidelines for peptic ulcer disease 2020 // Journal of Gastroenterology. – 2021. – Vol. 56, No. 4. – P. 303–322.

5.Laine L., Barkun A.N., Saltzman J.R., Martel M., Leontiadis G.I. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding // The American Journal of Gastroenterology. – 2021. – Vol. 116, No. 5. – P. 899–917.

6.Lanas A., Chan F.K.L. Peptic ulcer disease // The Lancet. – 2017. – Vol. 390, No. 10094. – P. 613–624.

Downloads

Published

2026-11-11